pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›IOHEXOL
drug · small molecule
save

IOHEXOL

Marketedupdated 3mo ago
by $AMRX Amneal Pharmaceuticals, Inc.🔗 ChEMBL
Approved
community read0 votes

🐶 often sniffed alongside

top 3
  • tagRecall4 co-mentions · 2 sources
  • tagApproval2 co-mentions · 1 sources
  • tagSmall Molecule1 co-mentions · 1 sources

Small molecule drug with a maximum clinical stage of Approval (across all indications), with 7 investigational indications.

all catalysts(1)

approval · 1
Nov 13, 2025
approval
$AMRX17.90-1.16%
9mo ago
IOHEXOL — FDA approval
IOHEXOL
→

Trials studying IOHEXOL

  • N/AMediBeacon® Transdermal GFR System for the Evaluation of Kidney Function in Adults With Heart Failurerecruitingn=15
  • phase1A Study of LY4515100 in Healthy Participantsrecruitingn=123
  • —Virtual Colonoscopy Using Omnipaque as a Contrast Agentcompletedn=50
  • phase4Chest CT Using Low-concentration Iodine Contrast Mediarecruitingn=370
  • phase2Pharmacokinetics of MB-102 and Use of the Non-invasive Optical Renal Function Monitor (ORFM) Device in Subjects With Normal and Impaired Renal Function and a Range of Skin Color Typescompletedn=234

Patent cliff

source: FDA Orange Book

FDA exclusivities (1)

  • Jul 26, 2026CGTCGT

News(0)

no news has mentioned this drug yet

brand
IOHEXOL
trade names
Exypaque, Omnipaque, Omnipaque 12, Omnipaque 140, Omnipaque 180, Omnipaque 210
generic
IOHEXOL
MOA
12.1 Mechanism of Action The iodine atoms in iohexol provide attenuation of X-rays in direct proportion to the concentration of iohexol. Since concentration changes over time, iohexol provides time-dependent image contrast which may assist in visualizing body structures.
phase
marketed
Data sources
openFDA · ClinicalTrials.gov · OpenTargets
last refreshed 4m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?